On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Global Services (Slovakia)

InstitutionResearch output, impact & collaborations

Global Services (Slovakia) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Global Services (Slovakia)?

ScholarIQrecord summary

Global Services (Slovakia) is a research organisation in Bratislava, SK. OpenAlex records 73,553 works and 27,352 citations for it. 428 researchers list it as their most recent affiliation.

How many works does Global Services (Slovakia) have?

ScholarIQindexed works

Global Services (Slovakia) has 73,553 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Global Services (Slovakia) have?

ScholarIQcitation count

Global Services (Slovakia) has 27,352 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Global Services (Slovakia)?

ScholarIQresearcher count

Global Services (Slovakia) has 428 researchers in the ScholarIQ index.

What is the average h-index at Global Services (Slovakia)?

ScholarIQavg h-index

Global Services (Slovakia) has an average h-index of 53 in OpenAlex.

What is the ROR of Global Services (Slovakia)?

ScholarIQror

The ROR for Global Services (Slovakia) is on the source record.

What is the OpenAlex record for Global Services (Slovakia)?

ScholarIQopenalex

The OpenAlex for Global Services (Slovakia) is on the source record.

Who are the most-cited researchers behind Global Services (Slovakia)?

ScholarIQtop researchers by citations
1
Sílvia de Sanjosé · Cervical Cancer and HPV Research
419 works16,447 citations

What are the most-cited papers on Global Services (Slovakia)?

ScholarIQmost cited works
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn, Elisabete Weiderpass, Laia Bruni, Sílvia de Sanjosé, Mona Saraiya, Jacques Ferlay, Freddie Bray
The Lancet Global Health. 20194,194 CitationsOPEN ACCESS
Carcinogenic human papillomavirus infection
Mark Schiffman, John Doorbar, Nicolas Wentzensen, Sílvia de Sanjosé, Carole Fakhry, Bradley J. Monk, Margaret Stanley, Silvia Franceschi
Nature Reviews Disease Primers. 20161,011 Citations
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium
Karin E. Smedby, Claire M. Vajdic, Michael O. Falster, Eric A. Engels, Otoniel Martı́nez-Maza, Jennifer Turner, Henrik Hjalgrim, Paolo Vineis, Adele Seniori Costantini, Paige M. Bracci, Elizabeth A. Holly, Eleanor V. Willett, John J. Spinelli, Carlo La Vecchia, Tongzhang Zheng, Nikolaus Becker, Sílvia de Sanjosé, Brian C.‐H. Chiu, Luigino Dal Maso, Pierluigi Cocco, Marc Maynadié, Lenka Foretová, Anthony Staines, Paul Brennan, Scott Davis, Richard K. Severson, James R. Cerhan, Elizabeth C. Breen, Brenda M. Birmann, Andrew E. Grulich, Wendy Cozen
Blood. 2008624 CitationsOPEN ACCESS
The natural history of human papillomavirus infection
Sílvia de Sanjosé, María Brotons, Miguel Ángel Pavón
Best Practice & Research Clinical Obstetrics & Gynaecology. 2017599 Citations
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
Nathaniel Rothman, Christine F. Skibola, Sophia Wang, Gareth J. Morgan, Qing Lan, Martyn T. Smith, John J. Spinelli, Eleanor V. Willett, Sílvia de Sanjosé, Pierluigi Cocco, Sonja I. Berndt, Paul Brennan, Angela Brooks‐Wilson, Sholom Wacholder, Nikolaus Becker, Patricia Hartge, Tongzhang Zheng, Eve Roman, Elizabeth A. Holly, Paolo Boffetta, Bruce K. Armstrong, Wendy Cozen, Martha S. Linet, F. Xavier Bosch, Maria Grazia Ennas, Theodore R. Holford, Richard P. Gallagher, Sara Rollinson, Paige M. Bracci, James R. Cerhan, Denise Whitby, Patrick S. Moore, Brian P. Leaderer, Agnes S. Lai, Charlotte F. Spink, S. Scott Davis, Ramón Bosch, Aldo Scarpa, Yawei Zhang, Richard K. Severson, Meredith Yeager, Stephen J. Chanock, Alexandra Nieters
The Lancet Oncology. 2005380 Citations

How much of the research on Global Services (Slovakia) is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
25%
Green
8%
Hybrid
17%
Bronze
17%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial